CAS Number143527-70-2
Synonyms(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid; (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid; T5N COTJ AVOX1&1&1 B1 B1 DVQ ER &&(4S,5R)- Form; (4S,5R)-3-(tBoc)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic Acid; (4S,5R)-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid
Molecular FormulaC17H23O5N1
Molecular Weight321.37
Density1.2±0.1 g/cm3
Boiling Point459.0±45.0 °C at 760 mmHg
Melting Point114 °C
AppearanceOff-white semi-solid
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 143527-70-2 |
| Catalog No. | 2A-9073753 |
| Chinese Name | (4S,5R)-2,2-二甲基-4-苯基-3-叔丁氧基羰基-3,5-氧氮杂环戊烷甲酸 |
| Synonyms | (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid; (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid; T5N COTJ AVOX1&1&1 B1 B1 DVQ ER &&(4S,5R)- Form; (4S,5R)-3-(tBoc)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic Acid; (4S,5R)-2,2-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid |
| Molecular Formula | C17H23O5N1 |
| Molecular Weight | 321.37 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 459.0±45.0 °C at 760 mmHg |
| Melting Point | 114 °C |
| Appearance | Off-white semi-solid |
| Storage Condition | Refrigerator |
| HTC | 2934999090 |
| PubChem ID | 16025435 |
| MDL Number | MFCD09263630 |
| SMILES | CC(C)(C)OC(=O)N1C(c2ccccc2)C(C(=O)O)OC1(C)C |
| InChI | InChI=1S/C17H23NO5/c1-16(2,3)23-15(21)18-12(11-9-7-6-8-10-11)13(14(19)20)22-17(18,4)5/h6-10,12-13H,1-5H3,(H,19,20)/t12-,13+/m0/s1 |
| InChI Key | VAHXMEZCPGHDBJ-QWHCGFSZSA-N |
| MSDS | msds/73753_1_143527_70_2.pdf |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (R)-1-benzyl-3-hydroxypiperidin-2-one | 614754-32-4 | 2A-9073728 |
| (2R,3S)-3-Phenylisoserinemethylester | 131968-74-6 | 2A-9073737 |
| (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine | 477600-70-7 | 2A-9073743 |
| (R)-tert-butyl6-oxopiperidin-3-ylcarbamate | 172913-96-1 | 2A-9073750 |
| (S)-tert-butyl6-oxopiperidin-3-ylcarbamate | 1228566-94-6 | 2A-9073751 |
| (4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylicacid | 153652-70-1 | 2A-9073755 |
| (S)-5-Amino-piperidin-2-oneHCl | 672883-95-3 | 2A-9073766 |
| 3(S)-HYDROXYMETHYLMORPHOLINE | 211053-50-8 | 2A-9073768 |
| (R)-1-((1-methylpyrrolidin-2-yl)methyl)piperidine | 155726-05-9 | 2A-9073774 |
| 3-TERT-BUTOXYCARBONYLAMINO-ISONICOTINICACID | 179024-65-8 | 2A-9073775 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS